Literature DB >> 8880514

Study of Abbott Toxo IMx system for detection of immunoglobulin G and immunoglobulin M toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis.

O Liesenfeld1, C Press, R Flanders, R Ramirez, J S Remington.   

Abstract

We compared the Abbott Toxo immunoglobulin G (IgG) and IgM IMx assays with the Sabin-Feldman dye test and an IgM enzyme-linked immunosorbent assay (ELISA) in 398 serum samples previously tested in our laboratory (retrospective group) and 1,000 consecutive serum samples, tested as they were received in our laboratory in 1995 (prospective group). In the retrospective group, the IgG IMx had a sensitivity of 100%, specificity of 99.0%, positive predictive value of 99.0%, negative predictive value of 100%, and overall agreement of 99.5%. The percentages for the IgM IMx were 97.8, 99.0, 98.9, 98, and 98.4%, respectively. In the prospective group, the IgG IMx had a sensitivity of 97.8%, specificity of 98.7%, positive predictive value of 97.8%, negative predictive value of 98.7%, and overall agreement of 98.4%. The percentages for the IgM IMx were 88.3, 95.9, 74.7, 98.3, and 95%. A serological profile (IgA and IgE antibodies and the differential agglutination [AC/HS] test) was performed in an attempt to resolve discrepancies. Of 21 serum samples that were positive in the IgM IMx and negative in the IgM ELISA, 19 had serological profiles which were most compatible with an infection acquired in the distant past. Of 8 serum samples which were positive in the IgM ELISA and negative in the IgM IMx, 5 had serological profiles which were most compatible with an infection acquired in the distant past. Of the 55 serum samples that were positive in both IgM tests, 21 were from patients who had serological profiles which were most compatible with an infection acquired in the distal past. In conclusion, our data highlight the importance of confirmatory testing for the diagnosis of recently acquired infection with Toxoplasma gondii. When compared with the dye test and IgM ELISA, the Toxo IgG and IgM IMx assays, respectively, revealed high overall agreement in the retrospective and prospective study.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880514      PMCID: PMC229310          DOI: 10.1128/jcm.34.10.2526-2530.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Statistical methods in microbiology.

Authors:  D M Ilstrup
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  Performance of European laboratories testing serum samples for Toxoplasma gondii.

Authors:  J C Petithory; I Reiter-Owona; F Berthelot; M Milgram; J De Loye; E Petersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

3.  IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis.

Authors:  P Stepick-Biek; P Thulliez; F G Araujo; J S Remington
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

4.  Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii.

Authors:  B R Dannemann; W C Vaughan; P Thulliez; J S Remington
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

5.  The Vitek immunodiagnostic assay for detection of immunoglobulin M toxoplasma antibodies.

Authors:  E Candolfi; R Ramirez; M P Hadju; C Shubert; J S Remington
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

Review 6.  Toxoplasmosis in pregnancy.

Authors:  S Y Wong; J S Remington
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

7.  Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity.

Authors:  G Desmonts; J S Remington
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

8.  An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis.

Authors:  Y Naot; J S Remington
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

9.  Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis.

Authors:  S Y Wong; M P Hajdu; R Ramirez; P Thulliez; R McLeod; J S Remington
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

10.  Studies on the serodiagnosis of toxoplasmic lymphadenitis.

Authors:  J G Montoya; J S Remington
Journal:  Clin Infect Dis       Date:  1995-04       Impact factor: 9.079

View more
  20 in total

1.  Intravenous immunoglobulin therapy: confounding effects on serological screening for toxoplasmosis during pregnancy.

Authors:  H Pelloux; H Fricker-Hidalgo; G Brochier; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.

Authors:  Jose G Montoya; Oliver Liesenfeld; Sandra Kinney; Cynthia Press; Jack S Remington
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

3.  Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.

Authors:  Elisa Beghetto; Andrea Spadoni; Luca Bruno; Wilma Buffolano; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems.

Authors:  W T Hofgärtner; S R Swanzy; R M Bacina; J Condon; M Gupta; P E Matlock; D L Bergeron; J J Plorde; T R Fritsche
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

5.  False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.

Authors:  O Liesenfeld; C Press; J G Montoya; R Gill; J L Isaac-Renton; K Hedman; J S Remington
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

6.  Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Authors:  O Villard; B Cimon; C L'Ollivier; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

7.  Seroreactivity to and avidity for recombinant antigens in toxoplasmosis.

Authors:  Klaus-Ingmar Pfrepper; Gisela Enders; Marion Gohl; Doris Krczal; Harald Hlobil; Doris Wassenberg; Erwin Soutschek
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

8.  Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen.

Authors:  S Li; G Maine; Y Suzuki; F G Araujo; G Galvan; J S Remington; S Parmley
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

9.  Recombinant mouse-human chimeric antibodies as calibrators in immunoassays that measure antibodies to Toxoplasma gondii.

Authors:  J Hackett; J Hoff-Velk; A Golden; J Brashear; J Robinson; M Rapp; M Klass; D H Ostrow; W Mandecki
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

10.  Simple and efficient method for measuring anti-toxoplasma immunoglobulin antibodies in human sera using complement-mediated lysis of transgenic tachyzoites expressing beta-galactosidase.

Authors:  C Dando; K E Gabriel; J S Remington; S F Parmley
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.